Plantago ovata and Ocimum basilicum Mucilages as Natural Superdisintegrants for Enhancing Disintegration, Dissolution and Oral Bioavailability: A Comprehensive Review

Oral solid dosage forms remain the most widely used and preferred route of drug administration owing to ease of self-administration, dosing accuracy, cost-effectiveness, and patient acceptability. A persistent challenge for conventional tablets, however, is achieving rapid disintegration and dissolution, particularly for pediatric, geriatric, and dysphagic patients, and for drugs whose oral bioavailability is limited by a slow rate of dissolution in the gastrointestinal tract. This has driven the development of fast-disintegrating, orodispersible, and mouth-dissolving tablet (ODT/MDT/FDT) technologies, in which the disintegrant is the single most influential excipient governing performance.

Disintegrants are classified as synthetic (e.g., croscarmellose sodium, crospovidone, sodium starch glycolate), semi-synthetic, and natural, with natural, plant-derived mucilages increasingly favored for their biocompatibility, biodegradability, low cost, and alignment with the pharmaceutical industry's broader shift toward green and sustainable excipients. Among natural sources, the mucilages of Plantago ovata Forsk. (isabgol/psyllium husk) and Ocimum basilicum L. (sweet basil) seeds have received sustained research attention over more than a decade because of their favorable swelling behavior, high water-holding capacity, and demonstrated ability to produce single-digit-second disintegration times in optimized formulations.

This review consolidates the published literature on P. ovata and O. basilicum mucilages as natural superdisintegrants, covering their botanical source and chemical composition, extraction and purification methods, mechanisms of disintegrant action, comparative and combined formulation performance, and their downstream implications for dissolution rate and oral bioavailability, with particular relevance to poorly water-soluble (BCS Class II) drug candidates.

1.1 Review Methodology

A structured literature search was performed across PubMed/MEDLINE, ScienceDirect, Google Scholar, and ResearchGate using combinations of the keywords "natural superdisintegrant," "Plantago ovata mucilage," "psyllium husk disintegrant," "Ocimum basilicum mucilage," "basil seed mucilage," "orodispersible tablet," and "fast disintegrating tablet." Original research articles, review articles, and technical monographs published primarily between 2007 and 2026 were screened for relevance; studies reporting formulation-level performance data (disintegration/dispersion time, wetting time, water absorption ratio, in vitro drug release) or mucilage characterization data (composition, swelling index, rheology) were prioritized for inclusion.

2. Superdisintegrants: Concept, Classification, and Mechanisms of Action

Superdisintegrants are excipients incorporated into solid dosage forms, typically at 1-10% w/w, to promote rapid breakup of the compressed tablet matrix on contact with an aqueous medium, thereby increasing the effective surface area available for drug dissolution. Unlike conventional disintegrants, superdisintegrants are effective at markedly lower concentrations owing to their more efficient water-uptake and matrix-disruption properties.

Disintegrants are broadly classified by origin into synthetic (e.g., crospovidone, croscarmellose sodium, sodium starch glycolate, ion-exchange resins), semi-synthetic, natural (plant mucilages and gums), and co-processed varieties. Several mechanisms have been proposed to explain disintegrant action, and it is generally accepted that no single mechanism operates in isolation; most agents act through a combination of pathways.

Figure 1. Predominant mechanisms of action underlying mucilage-based natural superdisintegrant performance: swelling, wicking (capillary action), and deformation recovery.

Swelling is generally regarded as the most significant mechanism for hydrophilic plant mucilages: on contact with water, the polysaccharide network absorbs fluid and expands, generating internal pressure that ruptures inter-particulate bonds within the tablet. Wicking refers to the capillary uptake of water through the porous tablet matrix, displacing adsorbed air and weakening the binder network, a mechanism that operates in parallel with swelling for many mucilages. Deformation recovery, particle-repulsion, heat of wetting, and (for select natural agents) enzymatic action have also been described, though these are comparatively less studied for plant-derived disintegrants.

Selection criteria for an ideal superdisintegrant include good mouth-feel, minimal gel formation (to avoid retarding dissolution once disintegration has occurred), high hydration capacity, absence of drug-excipient interaction, compatibility with co-formulated excipients, and acceptable powder-flow properties.

3. Plantago ovata Mucilage as a Natural Superdisintegrant

3.1 Botanical Source and Chemical Composition

Plantago ovata Forsk. (family Plantaginaceae), commonly known as isabgol or psyllium, is an annual herb cultivated extensively in India, Pakistan, and Iran, with India supplying approximately 85% of the world psyllium market. The husk, obtained by milling the seed, constitutes roughly 25-26% of seed weight and comprises about 34% insoluble fiber and 66% soluble fiber. The soluble fraction is dominated by a highly branched arabinoxylan polysaccharide, with reported arabinose:xylose ratios varying by source and extraction method (commonly cited in the range of approximately 1:3 to 1:0.4 arabinose:xylose depending on the fraction analyzed), together with minor proportions of galacturonic acid, protein (~0.94%), and ash (~4%). This arabinoxylan-rich matrix is responsible for the exceptional water-holding and gel-forming capacity that underlies its disintegrant behavior.

3.2 Extraction and Pharmaceutical Characterization

P. ovata mucilage is typically isolated by aqueous extraction of the husk or whole seed, followed by mechanical separation, filtration, and drying, with or without alcoholic precipitation to purify the polysaccharide fraction. The resulting mucilage or husk powder has been evaluated for micromeritic properties (angle of repose, Carr's index, Hausner ratio), swelling index, pH, viscosity, and Fourier-transform infrared (FTIR) spectral compatibility with model drugs prior to incorporation into tablet formulations.

3.3 Formulation Performance

P. ovata mucilage has been evaluated as a superdisintegrant across a range of fast-disintegrating and orodispersible tablet formulations. In a widely cited early study, Shirsand and Sarasija formulated fast-disintegrating tablets of prochlorperazine maleate using P. ovata mucilage (2-8% w/w) alongside microcrystalline cellulose and directly compressible mannitol; the optimized formulation containing 8% w/w mucilage and 60% w/w microcrystalline cellulose achieved an in vitro dispersion time of approximately 8 seconds, acceptable hardness (~2.63 kg/cm²), friability below 1%, and stable performance on short-term accelerated stability testing (40 °C/75% RH, 3 months).

Subsequent studies extended this approach to other model drugs. A 3² full factorial design study on domperidone fast-disintegrating tablets used P. ovata mucilage at 2-10% w/w with microcrystalline cellulose as diluent, evaluating hardness, friability, drug content uniformity, and in vitro dispersion, wetting, and water-absorption behavior. Mahant et al. formulated mouth-dissolving tablets of ondansetron hydrochloride using P. ovata mucilage as the sole natural superdisintegrant, with the optimized formulation (12% w/w mucilage) achieving a disintegration time of approximately 7 seconds and in vitro drug release of 98.57% within 15 minutes. P. ovata husk has also been used directly (without mucilage isolation) as a superdisintegrant in sublingual nifedipine tablets and in psyllium husk powder-based orodispersible meloxicam and valsartan formulations, the latter reporting a disintegration time of approximately 20.34 seconds, a wetting time of 12.60 seconds, and a water absorption ratio of 143.37 at effective concentrations.

4. Ocimum basilicum Mucilage as a Natural Superdisintegrant

4.1 Botanical Source and Chemical Composition

Ocimum basilicum L. (family Lamiaceae), commonly known as sweet basil, produces a hydrophilic mucilage layer in its seed testa on contact with water, yielding a translucent gel within minutes of soaking. Reported mucilage yield is approximately 20-20.5% w/w of dry seed mass. Compositionally, basil seed mucilage has been characterized as containing substantial proportions of glucomannan (approximately 43%) and xylan (approximately 24%), together with a smaller glucan fraction, conferring an anionic character due to ionizable carboxylate groups. A related structural analysis identified an acidic polysaccharide fraction composed of xylose, arabinose, rhamnose, and galacturonic acid with a (1→4)-linked xylan backbone bearing branched side chains. The polysaccharide is of high molecular weight (reported in the range of ~2,320 kDa in one structural study), and the total dietary fiber content of the isolated mucilage has been reported as high as 98.5%.

4.2 Extraction and Purification

Basil seed mucilage is conventionally obtained by soaking cleaned seeds in warm distilled water (commonly cited around 60-67 °C for periods ranging from approximately 20 minutes to 1.6 hours), followed by mechanical agitation to detach the swollen mucilage layer from the seed core, filtration through muslin cloth, centrifugation to remove residual particulates, and oven-drying at approximately 45 °C. Alcoholic precipitation has additionally been used to fractionate basil seed gum into alcohol-soluble and alcohol-insoluble polysaccharide fractions for more detailed structural characterization.

4.3 Formulation Performance

O. basilicum mucilage and defatted seed powder have been evaluated as superdisintegrants across several orodispersible and fast-dissolving tablet systems. Bucktowar et al. formulated fast-dissolving paracetamol tablets using O. basilicum seed mucilage as the superdisintegrant, reporting satisfactory hardness, friability, and disintegration performance. In a comparative dispersible-tablet study, Patil et al. evaluated O. basilicum mucilage alongside P. ovata mucilage and reported that the mucilage obtained from O. basilicum was effective in promoting disintegration, though a direct relationship between swelling index and disintegration efficiency was not consistently observed. O. basilicum defatted seed powder, used as a direct-compression disintegrant in clopidogrel orodispersible tablets at 3, 6, and 9% w/w, produced disintegration times below one minute across all tested concentrations, with the 9% w/w formulation achieving approximately 32 seconds and near-complete (99%) drug release within 10 minutes. Related work has also demonstrated the utility of basil seed mucilage beyond disintegrant applications, including as a bioadhesive polymer carrier for naproxen sodium microspheres and suppositories, and as a component of mucoadhesive sublingual films, reflecting the versatility of its polysaccharide matrix in oral and mucosal drug delivery.

5. Comparative and Combined Applications

Several studies have directly compared or combined P. ovata and O. basilicum mucilages within the same formulation platform. Lakshmi et al. isolated and purified Carica papaya and O. basilicum seed mucilages for the preparation of orodispersible valsartan tablets, identifying the 10% w/w O. basilicum mucilage formulation as an optimized batch on the basis of rapid in vitro dissolution. Patil et al.'s comparative dispersible-tablet study evaluated both P. ovata and O. basilicum mucilages relative to a starch-powder standard disintegrant, finding P. ovata mucilage effective at lower concentrations (around 5%) relative to the other natural agents tested. Factorial-design approaches combining P. ovata and O. basilicum mucilages within a single formulation (targeting further reductions in disintegration time through complementary swelling/wicking behavior) have also been described in the orodispersible tablet literature, illustrating an emerging strategy of using natural mucilage blends rather than single agents to further optimize disintegration performance.

Figure 2. Comparative in vitro disintegration/dispersion times reported across selected published studies using Plantago ovata and Ocimum basilicum mucilage-based formulations. Formulation compositions, model drugs, and test methodologies vary between studies; values are compiled for illustrative comparison only and are not directly interchangeable.

8. Regulatory Status, Safety, and Limitations

Unlike synthetic superdisintegrants, which are governed by well-established compendial monographs (USP, Ph. Eur., IP), most plant-derived mucilages — including P. ovata and O. basilicum mucilages — lack dedicated pharmacopeial specifications for use as pharmaceutical excipients, though psyllium husk itself carries a long history of regulatory acceptance in food and dietary-fiber applications. This absence of standardized specifications complicates formal regulatory submissions and requires manufacturers to generate in-house acceptance criteria for physicochemical and microbiological quality attributes, along with supporting safety and toxicity data. Reported limitations of natural superdisintegrants more broadly include batch-to-batch compositional variability arising from agro-climatic and geographic factors, higher microbial bioburden relative to synthetic agents, potential for allergenic reactions or gastrointestinal effects (e.g., flatulence, bloating) at high doses, and a comparative lack of long-term stability data under varied storage conditions.

9. Future Perspectives

Several directions appear well-positioned to strengthen the pharmaceutical case for P. ovata and O. basilicum mucilages going forward. First, adoption of Quality by Design (QbD) frameworks — including risk assessment (e.g., Ishikawa/fishbone analysis of extraction and formulation variables) and formal design-of-experiments (DoE) optimization — can help address the batch-variability concerns that currently limit regulatory confidence in natural excipients, by systematically defining a validated design space for mucilage extraction yield, purity, and disintegrant performance. Second, chemical modification strategies (e.g., graft copolymerization, cross-linking) applied to psyllium and basil-seed polysaccharides, as already explored in food and materials-science contexts, may be extended to tune swelling kinetics and gel strength specifically for pharmaceutical disintegrant applications. Third, formal application of green-chemistry excipient-assessment tools and life-cycle framing, consistent with the broader industry shift toward sustainable pharmaceutical development, would strengthen the evidence base positioning these mucilages as environmentally preferable alternatives to synthetic disintegrants. Finally, generation of pharmacopeial-grade reference specifications and expanded in vivo bioavailability data (beyond in vitro disintegration and dissolution surrogates) for representative BCS Class II drug candidates remain priority areas for translating the strong in vitro evidence base into regulatory and industrial adoption.

10. CONCLUSION

The published literature reviewed here consistently supports Plantago ovata and Ocimum basilicum mucilages as effective, low-cost, and biodegradable natural superdisintegrants capable of achieving disintegration performance competitive with, and in several optimized formulations superior to, established synthetic agents at comparable or lower use concentrations. Their predominant swelling and wicking mechanisms, well-characterized arabinoxylan- and glucomannan/xylan-rich polysaccharide compositions, and demonstrated compatibility across a range of model drugs and dosage-form platforms (fast-disintegrating, orodispersible, and mouth-dissolving tablets) provide a strong mechanistic and empirical basis for their continued use and further optimization. Given the well-established relationship between disintegration rate, dissolution rate, and oral bioavailability for BCS Class II drugs, these natural mucilages represent a pharmaceutically and environmentally attractive platform, contingent on continued progress toward standardized extraction protocols, pharmacopeial specifications, and expanded in vivo validation.

Conflict of Interest

The authors declare no conflict of interest.

ACKNOWLEDGMENT

The authors acknowledge [Institution/Department name] for providing the necessary literature access and support for this review.

REFERENCES

1. Shirsand SB, Sarasija S. Plantago ovata mucilage in the design of fast disintegrating tablets. Indian J Pharm Sci. 2009;71(1):41-45.
2. Formulation of fast disintegrating domperidone tablets using Plantago ovata mucilage by 3² full factorial design. Int Curr Pharm J. 2015;4(8):412-418.
3. Formulation and Evaluation of Fast Dissolving Sublingual Tablets of Nifedipine using Plantago ovata Husk as a Natural Superdisintegrant. Res J Pharm Technol. 2022;15(2).
4. Draksiene G, Kopustinskiene DM, Lazauskas R, Bernatoniene J. Psyllium (Plantago ovata Forsk) Husk Powder as a Natural Superdisintegrant for Orodispersible Formulations: A Study on Meloxicam Tablets. Molecules. 2019;24(18):3255.
5. Mahant S, Singla S, Goyal S, Kumari B, Soni A. Formulation and Evaluation of Mouth Dissolving Tablets of Ondansetron Hydrochloride Using Plantago ovata (Isapghula) Mucilage as Natural Super Disintegrating Agent. Int J Pharm Sci Drug Res. 2017;9(5):240-246.
6. Investigation of Plantago ovata Husk as Pharmaceutical Excipient for Solid Dosage Form (Orodispersible Tablets). [Internet]. PMC8219414.
7. Extractability and chemical and enzymic degradation of psyllium (Plantago ovata Forsk) seed husk arabinoxylans. Carbohydr Polym / J Cereal Sci [various years].
8. Psyllium Mucilage and Its Use in Pharmaceutical Field: An Overview. J Pharm Pharm Sci.
9. Nutritional Composition and Health Benefits of Psyllium (Plantago ovata) Husk and Seed. [Review].
10. Yu L, Yakubov GE, Zeng W, Xing X, Stenson J, et al. Multi-layer mucilage of Plantago ovata seeds: Rheological differences arise from variations in arabinoxylan side chains. Carbohydr Polym. 2017;165:132-141.
11. Singh B. Psyllium as therapeutic and drug delivery agent. Int J Pharm. 2007;334:1-14.
12. Santos R, Melo N, Sanches-Silva A. Psyllium (Plantago ovata Forsk): From evidence of health benefits to its food application. Trends Food Sci Technol. 2020;96:166-175.
13. The role and therapeutic effectiveness of Plantago ovata seed husk (psyllium husk) in the prevention and non-pharmacological treatment of gastrointestinal diseases. Part 1. [Review, PubMed].
14. Lakshmi MP, Shailaja P, Jagan NV, Narendra D. Isolation, Purification of Carica Papaya and Ocimum basilicum Seed Mucilages and Preparation of Valsartan Oro Dispersible Tablets by Using Natural Superdisintegrants. Int J Sci Dev Res. 2019;4(1):41-48.
15. Bucktowar K, Sandeep B, Mili B, Bholoa L, Ganesh K. Formulation and Evaluation of Fast Dissolving Tablets of Paracetamol using Ocimum basilicum Seed Mucilage as Superdisintegrant. Int Res J Pharm Biosci. 2017;4(1):44-55.
16. Rusu A, et al. Emerging Perspectives in the Formulation of Lyophilized Orally Disintegrating Tablets: From Lyoc to Self-Nanoemulsifying Lyophilized Tablets (SNELTs) and Beyond into Hybrid Platforms. Pharmaceutics/Pharmaceutical Excipients Review. 2024.
17. Patil VA, et al. Study of Ocimum basilicum and Plantago ovata as disintegrants in the formulation of dispersible tablets. J Drug Deliv Ther. 2013;3(5):44-48.
18. Functional characterization of basil (Ocimum basilicum L.) seed mucilage. Food Hydrocolloids / Int J Biol Macromol.
19. Fractionation and characterization of mucilage from Basil (Ocimum basilicum L.) seed. Carbohydr Polym Technol Appl. 2022.
20. Basil seed mucilage as a bioadhesive polymer: Development of naproxen sodium microspheres and suppositories with in-vitro and ex-vivo studies. [PMC11661803].
21. Effect of mucilage extracted from Basil (Ocimum basilicum L.) seeds on physicochemical and rheological properties in low-fat milk protein gel. Int J Biol Macromol. 2019.
22. Nazir S, Wani IA, Masoodi FA. Insights into the basil seed: Unveiling its composition and promising role in the food industry. Food Chem Adv. 2025.
23. The Renaissance of Plant Mucilage in Health Promotion and Industrial Applications: A Review. Nutrients. 2021;13(10):3354.
24. A Brief Review on Natural and Synthetic Superdisintegrants. [Review article].
25. Natural Superdisintegrants for the Formulation of Orally Disintegrating Tablets. Int J Res Rev. 2021;8(11).
26. An Overview: On Superdisintegrants. PharmaTutor. 2013.
27. A Detailed Study on Disintegrants and Superdisintegrants. [Review, ResearchGate].
28. A Comprehensive Review of Disintegrants: Backbone of Disintegration. Pharmaceutical Excipients Review. 2024.
29. Superdisintegrants and Their Working Mechanisms. DFE Pharma Technical Paper. 2021.
30. Review of Disintegrants and the Disintegration Phenomena. J Pharm Sci. 2016;105(9):2545-2555.
31. Natural Superdisintegrants in the Formulation of Fast Disintegrating Tablets: Current Trends and Challenges. Int J Adv Res Sci Commun Technol. 2024.
32. A Review of Natural vs. Synthetic Disintegrants: Comparative Study and Future Perspectives. J Chem Health Risks. 2024;14.
33. Superdisintegrants: Brief Review. J Drug Deliv Ther. 2022;12(1):170-175.
34. An Overview on FDA-Approved Natural Super Disintegrants Efficacy in a Fast Dissolving Drug Delivery System. J Appl Pharm Res. 2021.
35. Bhatti S, Kaushik M. Utilization of natural superdisintegrants in mouth dissolving tablet: A simplified review. Innov Int J Med Pharm Sci.
36. Ali J, et al. Investigation of the effect of solubility increase at the main absorption site on bioavailability of BCS class II drug (risperidone) using liquisolid technique. [PMC8241109].
37. Design of Experiment Approach for Enhancing the Dissolution Profile and Robustness of Loratadine Tablet Using D-α-Tocopheryl Polyethylene Glycol 1000 Succinate. Pharmaceutics. [PMC11946126].
38. Development of Robust Tablet Formulations with Enhanced Drug Dissolution Profiles from Centrifugally-Spun Micro-Fibrous Solid Dispersions of Itraconazole, a BCS Class II Drug. [PMC10053999].